Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Online Network.
Celcuity Announces Clinically Meaningful Improvement in Both Progression-Free Survival (“PFS”) Primary Endpoints from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial
GlobeNewswire, Inc.
·
July 28, 2025
Hazard Ratios and Improvements in Median PFS are Unprecedented in HR+/HER2- Advanced Breast Cancer (“ABC”) Gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) reduced the risk of disease progression or death by 76% vs. fulvestrant...
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
GlobeNewswire, Inc.
·
July 28, 2025
Lu177-B7H3 monoclonal antibody is first in class targeted radiopharmaceutical in development against the 4lg subtype of B7-H3 On track to initiate first-in-human study of RV-01 in solid tumors in 4Q25 SYDNEY, July 28, 2025 (GLOBE NEWSWIRE) --...
Apyx Medical Corporation Announces Launch of Renuvion® in China
GlobeNewswire, Inc.
·
July 28, 2025
Strong clinical interest and early procedures completed Entered into distribution agreement with GlamMoon, a division of BeauCare Clinics Investment Co., Ltd. post-initial market clearance CLEARWATER, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Apyx...
Smith Profits Offers Shriners Children's Hospital the Opportunity to Transform Young Patients into #1 Best Selling Authors Through Patriotic Book Series
GlobeNewswire, Inc.
·
July 28, 2025
WINTER GARDEN, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Smith Profits, the Winter Garden, Florida-based business consulting and publishing company, announced a groundbreaking opportunity for Shriners Children's Hospital to launch "WHAT I LOVE ABOUT...
Immutep Announces Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
GlobeNewswire, Inc.
·
July 28, 2025
SYDNEY, AUSTRALIA, July 28, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces three abstracts for clinical...
Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C
GlobeNewswire, Inc.
·
July 28, 2025
CELEBRATION, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare diseases, announced the company submitted...
Genetic Testing Market to Soar to $54.2B by 2033, Driven by Personalized Medicine and Tech Innovation
EIN Presswire
·
July 28, 2025
With a CAGR of 15.4%, the genetic testing market is fueled by rising disease prevalence, DTC demand, and major M&A activity in 2025. LOS ANGELES, CA, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- The global genetic testing market size was...
Smith Profits and Junior Patriots Offer St. Jude Children's Research Hospital the Opportunity to Help Patients Become #1 Best Selling Authors
GlobeNewswire, Inc.
·
July 28, 2025
WINTER GARDEN, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Smith Profits, the Winter Garden-based business consulting and publishing firm, announces a groundbreaking corporate social responsibility initiative to offer St. Jude Children's Research...
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire, Inc.
·
August 2, 2025
NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) resulting from allegations...
Ex Vivo Drug Response Platform From KYAN Shows Clinical Utility in Non-Hodgkin Lymphoma Patients
EIN Presswire
·
July 28, 2025
Optim.AI™ accurately predicted response in prospective cohort; results published in JCO Precision Oncology, a journal of ASCO SINGAPORE, July 27, 2025 /EINPresswire.com/ -- A prospective clinical study published in JCO Precision Oncology, a...
Proteomics Market Booming with Biomarker Discovery and Precision Medicine Advancements, 2032 | Coherent Market Insights
EIN Presswire
·
July 28, 2025
BURLINGAME, CA, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- The latest Proteomics Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected...
Bragar Eagel & Squire, P.C. Is Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm
GlobeNewswire, Inc.
·
August 2, 2025
NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation (NASDAQ:NEOG),...
TrimIQ Weight Loss: Official launched in UK and Ireland With Green Tea Probiotic Complex
GlobeNewswire, Inc.
·
August 2, 2025
New York City, NY, Aug. 02, 2025 (GLOBE NEWSWIRE) -- TrimIQ UK, a pioneering health and wellness brand, proudly announces the launch of its ground-breaking weight management solution, TrimIQ. Designed to empower individuals to achieve their health...
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BHVN
GlobeNewswire, Inc.
·
August 2, 2025
NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025, both dates inclusive (the “Class Period”),...
ThinkCareBelieve: Week 28 America’s Success in President Trump’s Care
GlobeNewswire, Inc.
·
August 2, 2025
Washington, DC, Aug. 02, 2025 (GLOBE NEWSWIRE) -- Link to ThinkCareBelieve's Article: https://thinkcarebelieve.blog/2025/08/02/week-28-americas-success-in-president-trumps-care/ Week 28 of the Trump 2.0 Administration has been a climbing success...
MediciNova Provides Enrollment Update for Ongoing ALS and Hypertriglyceridemia Clinical Trials
GlobeNewswire, Inc.
·
July 24, 2025
LA JOLLA, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), today...
Butera 28 Apartments Blends History and Hospitality: The Hotel-Palazzo-Museum Every Literature Lover Must Visit
EIN Presswire
·
July 27, 2025
PALERMO, ITALY, July 27, 2025 /EINPresswire.com/ -- For literary travellers and history buffs alike, Butera 28 Apartments offers a rare opportunity to reside in the former home of Giuseppe Tomasi di Lampedusa, author of the Italian literary...
Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits
GlobeNewswire, Inc.
·
August 2, 2025
If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648 NEW YORK,...
Medical Alert Systems Sector Expected to Grow 10.9% Annually to $20.95 Billion by 2030, North America Leads
EIN Presswire
·
July 23, 2025
Medical alert systems market was valued at $6.47 billion in 2020, is projected to reach $20.95 billion by 2030, registering a CAGR of 10.9% from 2021 to 2030. WILMINGTON, NEW CASTLE, DE, UNITED STATES, July 23, 2025 /EINPresswire.com/ --...
Medical Silicone Molding Market is Forecasted to Reach US$5.9 Billion in 2030, Says Stratview Research
GlobeNewswire, Inc.
·
July 23, 2025
Detroit, July 23, 2025 (GLOBE NEWSWIRE) -- The global medical silicone molding market size was valued at US$3.8 billion in 2023 and is projected to reach US$5.9 billion by 2030, witnessing a market growth CAGR of 6.3% from 2024 to 2030, according...